

Neil Betteridge
5.9K posts

@Neil_Betteridge
Patient advocate; Senior Director for Europe, Global Alliance for Patient Access (GAfPA); Executive / WHO Liaison, Global Alliance for Musculoskeletal Health.













There is a need to invest more in the treatment of patients with inflammatory rheumatic disease. If more people achieve better disease control and remission, it will benefit patients, the health care system, and society. Listen now to @spondylitten's podcast episode with rheumatologist Gunnstein Bakland and an introduction by GRC's Chair @Neil_Betteridge: bit.ly/3NxxZkZ











In 2025, GRC advanced patient-centered policies that elevate remission in chronic inflammatory conditions as a priority. In 2026, GRC is committed to building on this momentum and putting #remission firmly on the policy agenda across the globe. #ThePursuitIsOn Read more: bit.ly/4rXeNN6







The idea of remission for AiArthritis diseases used to feel out of reach. Today, that is changing. In our newest episode, Leila sits down with @Neil_Betteridge from the @globalremission to explore what remission really means, why it matters, and how more patients can get there. They talk about early diagnosis, timely access to treatment, barriers that still stand in the way, and what helps people stay in remission once they reach it. If you or someone you support is navigating the patient journey, this conversation offers clarity, hope, and practical guidance. bit.ly/3XPooYB #remission #AiArthritis #autoimmunediseases

